We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$118M
This Fund
S&P 500
This Quarter
Est. Return
+5.45%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$180M
AUM Growth
+$35.3M
(+24%)
Cap. Flow
+$33.3M
Cap. Flow
% of AUM
18.49%
Top 10 Holdings %
Top 10 Hldgs %
21.58%
Holding
287
New
78
Increased
46
Reduced
73
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$4.54M |
| 2 |
Coherus Oncology
CHRS
|
+$3.29M |
| 3 |
Amylyx Pharmaceuticals
AMLX
|
+$2.71M |
| 4 |
Embecta
EMBC
|
+$2.55M |
| 5 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$2.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$4.1M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.81M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.81M |
| 4 |
Innoviva
INVA
|
+$2.07M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$1.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 59.9% |
| 2 | Real Estate | 10.66% |
| 3 | Financials | 4.01% |
| 4 | Technology | 3.46% |
| 5 | Consumer Discretionary | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
The Mosaic Company
MOS
$7.09B
| $169K | 0.09% |
4,825
-2,201
| -31% | -$85.1K |
|
152
Uber
UBER
$134B
| $167K | 0.09% |
+3,871
| New | +$144K |
|
|
CBAY
153
DELISTED
Cymabay Therapeutics
CBAY
| $164K | 0.09% |
+15,000
| New | +$140K |
|
154
iShares MSCI Poland ETF
EPOL
$669M
| $157K | 0.09% |
8,208
-32
| -0.4% | -$568 |
|
155
iShares MSCI Brazil ETF
EWZ
$9.05B
| $157K | 0.09% |
+4,836
| New | +$144K |
|
156
Ford
F
$57.3B
| $152K | 0.08% |
+10,078
| New | +$127K |
|
157
CALL
United Rentals
URI
$71.1B
| $152K | 0.08% |
+342
| New | +$127K |
|
|
GREK
158
Global X MSCI Greece ETF
GREK
$288M
| $152K | 0.08% |
4,099
-831
| -17% | -$27.8K |
|
|
EQRX
159
DELISTED
EQRx, Inc. Common Stock
EQRX
| $149K | 0.08% |
+80,000
| New | +$143K |
|
160
iShares MSCI India ETF
INDA
$6.71B
| $146K | 0.08% |
+3,342
| New | +$138K |
|
161
Carnival Corporation Ltd
CCL
$36.1B
| $145K | 0.08% |
+7,722
| New | +$90.3K |
|
162
iShares MSCI Peru and Global Exposure ETF
EPU
$534M
| $145K | 0.08% |
4,736
-791
| -14% | -$24.3K |
|
163
iShares MSCI Mexico ETF
EWW
$1.89B
| $145K | 0.08% |
2,329
-456
| -16% | -$27.9K |
|
164
iShares MSCI Chile ETF
ECH
$1.01B
| $144K | 0.08% |
4,932
-778
| -14% | -$22.5K |
|
165
iShares MSCI Taiwan ETF
EWT
$10B
| $142K | 0.08% |
3,017
+43
| +1% | +$1.96K |
|
166
iShares MSCI South Korea ETF
EWY
$21.7B
| $141K | 0.08% |
+2,220
| New | +$139K |
|
167
Cenovus Energy
CVE
$54.6B
| $138K | 0.08% |
8,147
-8,111
| -50% | -$137K |
|
168
EOG Resources
EOG
$78B
| $138K | 0.08% |
1,205
-26
| -2% | -$2.97K |
|
169
iShares MSCI Indonesia ETF
EIDO
$476M
| $137K | 0.08% |
+5,961
| New | +$141K |
|
170
General Motors
GM
$74.7B
| $137K | 0.08% |
+3,546
| New | +$123K |
|
171
Hewlett Packard
HPE
$63.2B
| $134K | 0.07% |
7,969
-8,349
| -51% | -$128K |
|
172
iShares MSCI Italy ETF
EWI
$911M
| $133K | 0.07% |
4,174
-580
| -12% | -$18K |
|
173
iShares MSCI Spain ETF
EWP
$1.98B
| $133K | 0.07% |
4,585
-620
| -12% | -$17.5K |
|
174
HCA Healthcare
HCA
$84.8B
| $131K | 0.07% |
+431
| New | +$120K |
|
175
iShares MSCI France ETF
EWQ
$324M
| $129K | 0.07% |
3,348
-559
| -14% | -$21.5K |
|
Similar funds
AIS
IVGAI
OIM
TIP
RCG
CWM
SPW
WLC
AlphaCentric Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, AlphaCentric Advisors held 287 positions worth $180M, up 24% from $145M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
AlphaCentric Advisors deployed $33.3M of net new capital in Q2 2023, opening 78 new positions and adding to 46 existing holdings. Its largest new stake was Embecta: 93,500 shares worth $2.02M.
By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 56% a quarter earlier, followed by Real Estate and Financials.
On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $4.1M trimmed.
- AlphaCentric Advisors's largest Q2 2023 buy was Embecta: 93,500 shares worth $2.02M.
- AlphaCentric Advisors added most to Jazz Pharmaceuticals in Q2 2023, an estimated $4.54M increase.
- AlphaCentric Advisors's biggest Q2 2023 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $4.1M.
- AlphaCentric Advisors fully exited Invesco QQQ Trust in Q2 2023, selling an estimated $2.81M.
- AlphaCentric Advisors's ten largest holdings make up 22% of its $180M portfolio in Q2 2023.
- AlphaCentric Advisors opened 78 new positions and closed 55 in Q2 2023.
- AlphaCentric Advisors's portfolio value rose 24% quarter-over-quarter to $180M.
Based on AlphaCentric Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.